09.01.2020 • NewsChemoursElaine Burridge

Chemours Sells Methylamines to Belle Chemical

Chemours Sells Methylamines to Belle Chemical
Chemours Sells Methylamines to Belle Chemical

Chemours has sold its methylamines business to Belle Chemical, an affiliate of Cornerstone Chemical, with effect from 1 January.

Interest in buying the business surfaced after Chemours announced last September that it would stop producing methylamines at its plant in Belle, West Virginia, USA, laying off 57 workers.

The decision was said to be driven by the rising costs of importing feedstocks such as methanol and ammonia along with the company’s wish to exit the business. Methylamines are used in a variety of applications in the agricultural, oil & gas, electronics and personal care industries, among others.

Chemours said it received “multiple inbound inquiries” from interested parties and hired investment bank Grace Matthews as an advisor.

Formerly the intermediate chemicals business of Cytec Industries, Cornerstone Chemical is owned by private equity firm Littlejohn & Co, which bought the Waggaman, Louisiana-based manufacturer from an affiliate of H.I.G. Capital in 2017.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read